The FDA has expanded the emergency use authorization (“EUA”) that was previously granted to mRNA-based COVID-19 vaccines of Moderna MRNA, and Pfizer PFE and BioNTech BNTX for use in the youngest population. Moderna’s Spikevax, and Pfizer and BioNTech’s Comirnaty are now a
More Stories
Stellantis looks beyond SUV era with new Peugeot 408
Rail strike: Disruption to continue as talks to end dispute resume
Galapagos Acquires CellPoint And AboundBio